State of the art software gives researchers the support they need

Global leader in evidence-based healthcare, JBI at the University of Adelaide, has released enhanced software that assists researchers for the entire process of conducting a systematic review.

The ‘all-in-one’ systematic review software, JBI SUMARI, provides end to end support for researchers, students and practitioners in health, social sciences and humanities, from protocol development to writing a systematic review report.  

The updated JBI SUMARI aligns to PRISMA 2020 requirements, including the ability to export the new PRISMA 2020 flow diagram. This flow diagram is automatically completed based on the decisions made during the screening and selection process within JBI SUMARI.

​

High quality systematic reviews are critical to provide trustworthy, evidence-based information for policy makers and clinicians to inform their decisions. However, systematic reviews are traditionally time consuming and difficult to do due to the rigorous methodological standards researchers need to follow. JBI SUMARI helps to support authors to do systematic reviews with software designed to guide and streamline the review process.

JBI SUMARI streamlines the process of conducting a systematic review by providing tools such as the report builder with its in-built citation management and automatic generation of appendices, and superior user interface which supports three different types of data synthesis, making meta-analysis and qualitative synthesis simple.  

A team of expert researchers and software programmers has developed the new JBI SUMARI, using JBI’s world-leading systematic review methodologies, approved by an international scientific committee of evidence synthesis experts. The team is led by Assoc Prof Zachary Munn, Director of Transfer Science at JBI.

“We are really excited about the unique features of JBI SUMARI, which is the only software that provides an efficient and seamless workflow for ten different types of systematic reviews including scoping reviews, qualitative reviews, mixed methods reviews and diagnostic test accuracy”, says Assoc Prof Munn. 

High quality reviews which have been conducted using JBI SUMARI have impact, such as the systematic review which resulted in safer communities and a review that contributed to WHO guidelines.  The journal, JBI Evidence Synthesis, publishes reviews that use JBI SUMARI.

The team is particularly excited about features such as the ability to screen both title and abstract from imported studies, in addition to screening at the full text level; the ability to screen studies within multiple study screeners, including logic to resolve conflicts; and the automatic generation of PRISMA 2020 flow diagrams to document the whole process.  

JBI SUMARI has been updated to align to the new PRISMA 2020 requirements, including the ability to export the new PRISMA 2020 flow diagram! This flow diagram is automatically completed based on the decisions your team makes during the screening and selection process within JBI SUMARI 

‘The innovative capabilities of JBI SUMARI include enabling multiple review authors to assess risk of bias with ease, within the software’, said Assoc Prof Munn.

The new JBI SUMARI now offers individual subscriptions and is available for free trial from the JBI SUMARI website.

JBI is an international research organisation based in the Faculty of Health and Medical Sciences at the University of Adelaide, South Australia. JBI develops and delivers unique evidence-based information, software, education and training designed to improve healthcare practice and health outcomes.

More information
jbisumari.org